Institutional Ownership Avadel Pharmaceuticals PLC (AVDL)
This table provides information about the institutional ownership of Avadel Pharmaceuticals PLC (AVDL). We have compiled data on the 7 institutions that hold shares in the stock, with a total of 738,134 shares, which have been reported (via 13F filing form) to have a value of $11.3 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Knoll Capital Management, LLC
Miami, FL |
Aug 14, 2025 Q2 2025 |
600,000
shares
|
$9.16 Million
3.61% of portfolio
|
Q3 2023
Added 20.0%
|
|
|
Schulhoff & CO Inc
|
Jul 30, 2025 Q2 2025 |
137,500
shares
|
$2.1 Million
0.58% of portfolio
|
Q1 2025
Added 0.36%
|
|
|
American Portfolios Advisors
Holbrook, NY |
Mar 17, 2023 Q3 2022 |
500
shares
|
$7,630
0.0% of portfolio
|
Q3 2022
New holding
|
|
|
American Research & Management Co.
|
Oct 07, 2022 Q3 2022 |
100
shares
|
$1,526
0.0% of portfolio
|
Q3 2020
New holding
|
|
|
Exane Derivatives
|
Jul 12, 2022 Q2 2022 |
33
shares
|
$503
0.0% of portfolio
|
Q1 2022
Reduced 86.25%
|
|
|
Huntington National Bank
Columbus, OH |
Aug 05, 2025 Q2 2025 |
1
shares
|
$15
0.0% of portfolio
|
Q4 2021
New holding
|